29
Fri, Mar
38 New Articles

Lawin Represents Ladee Pharma Against Bayer in “Groundbreaking" Estonian Patent Disputes

Estonia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Lawin is representing Ladee Pharma in three extensive patent disputes against Bayer — the first of which was recently resolved by the circuit court in favor of Ladee Pharma. According to Lawin, “ such judicial proceedings between pharmaceutical companies are rare in the Estonian legal landscape and significantly affect the end-consumers of the medicinal products.”

Lawin reports that Ladee Pharma Baltics, a pharmaceutical company focused on the commercialization of generic medicinal products, and Bayer Pharma, a manufacturer of original medicinal products, have been litigating over the revocation of patents registered in Bayer’s name since 2011. If the patents are revoked, the Estonian pharmaceuticals market would be opened up for Ladee Pharma Baltics and other producers of generic pharmaceuticals with regard to the medicinal products currently protected by Bayer's patents. 

On July 15, 2014, the Tallinn Circuit Court upheld the previous county court judgment and satisfied the action of Ladee Pharma Baltics in the full extent by revoking one of the patents registered in Bayer’s name. Separate proceedings regarding a second challenged patent are ongoing.

Lawin attorney-at-law Kadri Michelson and an unnamed patent agent are representing Ladee Pharma Baltics in the proceedings.